ADDvise Group
ADDvise receives order worth USD 3 million
ADDvise Group AB’s subsidiary MRC Systems FZE has received an order from Leader Life Sciences, part of Dubai-based Leader Healthcare Group. Leader Life Sciences is a specialist company aiming to introduce ground-breaking scientific technologies and solutions in the fields of biomedical sciences, biotechnology, drug discovery, environmental sciences, and precision medicine.
The order is worth approximately USD 3 million and involves the design, supply, installation, and commissioning of a cleanroom and associated accessories for a new biotechnology research facility based in Abu Dhabi. Delivery of the order is scheduled for Q2 and Q3 2024.
For further information, please contact:
Rikard Akhtarzand, CEO
+46 765-25 90 71
rikard.akhtarzand@addvisegroup.se
Important information
This information is information that ADDvise Group AB is required to disclose under the EU Market Abuse Regulation. The information was submitted for publication on December 29, 2023 at 14:10 CET.
About ADDvise Group
ADDvise Group AB (publ) is a leading supplier of equipment to healthcare and research facilities. The group consists of two business areas, Lab and Healthcare. Sales are global. The Group has a clear acquisition strategy with the aim of raising shareholder value and expand the business - both geographically and product wise. ADDvise Group's shares are listed on Nasdaq First North Premier Growth Market and Mangold Fondkommission AB is the Company's Certified Adviser. Additional information is available at www.addvisegroup.com.
Datum | 2023-12-29, kl 14:10 |
Källa | Cision |
![](https://static.allaaktier.se/ads/hand-waving-2.png)